BCLS SB Investco, LP - 19 Feb 2025 SCHEDULE 13D/A Report for Solid Biosciences Inc. Common Stock, $0.001 par value per share (SLDB)

Filing Manager
BCLS SB Investco, LP
Reporting Manager
BCLS II Investco, LP
Security
Solid Biosciences Inc. Common Stock, $0.001 par value per share
Symbol
SLDB
Shares outstanding
79,218,487 shares
Disclosed Ownership
6,179,042 shares
Ownership
7.8%
Form type
SCHEDULE 13D/A
Filing time
21 Feb 2025, 18:04:54 UTC
Date of event
19 Feb 2025
Next filing
10 Mar 2026
SEC
View on sec.gov

Sponsored

Quoteable Key Fact

"BCLS SB Investco, LP disclosed 7.8% ownership in Solid Biosciences Inc. Common Stock, $0.001 par value per share (SLDB) on 19 Feb 2025."

Quick Takeaways

  • BCLS SB Investco, LP filed SCHEDULE 13D/A for Solid Biosciences Inc. Common Stock, $0.001 par value per share (SLDB).
  • Disclosed ownership: 7.8%.
  • Date of event: 19 Feb 2025.

What Changed

  • No earlier schedule filing is available for direct comparison.
  • Current filing was accepted on 21 Feb 2025, 18:04.

Why This Matters

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Official SEC Source

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting Managers (5)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
BCLS SB Investco, LP 0.7% 528,660 0 528,660 /s/ Adam Koppel Adam Koppel, Partner of Bain Capital Life Sciences Investors, LLC 0001728056
Bain Capital Life Sciences Fund II, L.P. 0.3% 267,257 0 267,257 /s/ Adam Koppel Adam Koppel, Partner of Bain Capital Life Sciences Investors, LLC 0001773187
BCLS II Investco, LP 7.8% 6,179,042 0 6,179,042 /s/ Adam Kopppel Adam Koppel, Partner of Bain Capital Life Sciences Investors, LLC 0001818893
BCIP Life Sciences Associates, LP 0.04% 32,550 0 32,550 /s/ Adam Koppel Adam Koppel, authorized signatory of Boylston Coinvestors, LLC 0001702921
BCLS II Equity Opportunities, LP 1.1% 904,160 0 904,160 /s/ Adam Koppel Adam Koppel, Partner of Bain Capital Life Sciences Investors, LLC 0001814474

Sponsored